Concepedia

Hongyan Liu

HL

Statistics

Publications

30

Citations

1.7K

H-Index

20

Active since

1998

Affiliations

Wuhan University(Current)

Renmin Hospital of Wuhan University

Chinese Academy of Medical Sciences & Peking Union Medical College

Xuzhou Medical College

University of Pennsylvania

Hongyan Liu is an author at Wuhan University specializing in medicine, cell biology, and pharmacology.

ORCID

Top concepts

Publications per year

1998–2024

30

Publications

30

Risk-Adapted Preemptive Tocilizumab to Prevent Severe Cytokine Release Syndrome After CTL019 for Pediatric B-Cell Acute Lymphoblastic Leukemia: A Prospective Clinical Trial

Stephan Kadauke, Regina M. Myers, Yimei Li et al. · Journal of Clinical Oncology · 2021 · 201 citations · Full text

Humanized CD19-Targeted Chimeric Antigen Receptor (CAR) T Cells in CAR-Naive and CAR-Exposed Children and Young Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia

Regina M. Myers, Yimei Li, Allison Barz Leahy et al. · Journal of Clinical Oncology · 2021 · 177 citations · Full text

The antiparasitic drug ivermectin is a novel FXR ligand that regulates metabolism

Lihua Jin, Xuhui Feng, Hui Rong et al. · Nature Communications · 2013 · 151 citations · Full text

, , +7

Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models

Qing Zhang, Haixu Zhang, Jiage Ding et al. · Journal of Immunology Research · 2018 · 149 citations · Full text

Cancer chemopreventive and therapeutic activities of red ginseng

Xiaoguang Chen, Hongyan Liu, Lei Xiaohong et al. · Journal of Ethnopharmacology · 1998 · 133 citations

, , +5

1–5 of 30